Skip to main content
logo
Oatly Group AB (OTLY)
NASDAQ: OTLY · Real-Time Price · USD
16.49
-0.02 (-0.12%)
Aug 11, 2025, 1:23 PM - Market open

Inozyme Pharma Revenue

Oatly had revenue of $208.35M in the quarter ending June 30, 2025, with 3.05% growth. This brings the company's revenue in the last twelve months to $828.20M, up 4.43% year-over-year. In the year 2024, Oatly had annual revenue of $823.67M with 5.15% growth.

Revenue (ttm)
$828.20M
Revenue Growth
+4.43%
P/S Ratio
0.60
Revenue / Employee
$558,839
Employees
1,482
Market Cap
493.51M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024823.67M40.32M5.15%
Dec 31, 2023783.35M61.11M8.46%
Dec 31, 2022722.24M79.05M12.29%
Dec 31, 2021643.19M221.84M52.65%
Dec 31, 2020421.35M217.30M106.50%
Dec 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Walmart685.09B
Costco Wholesale268.78B
PepsiCo91.75B
The Procter & Gamble Company84.28B
Unilever70.19B
Anheuser-Busch InBev58.52B
The Coca-Cola Company47.06B
Philip Morris International39.06B
Revenue Rankings

OTLY News

More News